StratumSkin science, cited
BIngredients·8 min·6 sources

Niacinamide: what it actually does, one claim at a time

It's in everything, it costs very little, and the bottle promises considerably more than the studies deliver.

Disclosure

Nothing here is sponsored and we earn nothing from anything mentioned. If that ever changes, this box will say so before you read a word of the article.

Evidence at a glance

Barrier repair
B Genuinely helps. This is the reason to use it.
Dark spots
B Real. One head-to-head trial ran it close to hydroquinone, with fewer side effects.
Oiliness
C One small study at 2%. Widely quoted, rarely repeated.
Wrinkles
C Significant on photographs in a company-run trial. Nobody asked whether it shows.
Tolerability
A Very well tolerated up to 5%. Almost nobody reacts.

Niacinamide is the beige cardigan of skincare. It goes with everything, it never causes a scene, and most people aren't entirely sure what it's for.

The bottle usually claims it handles pores, pigment, oil, fine lines, redness and your skin barrier. That's a lot of jobs for one small molecule. Some of it holds up beautifully. Some of it is one small study wearing a very convincing trench coat.

The claim worth buying it for

Think of your skin's outer layer as a brick wall. The cells are the bricks. The greasy stuff packed between them is the mortar. When the mortar runs thin, water escapes, irritants sneak in, and your face starts reacting to products it happily tolerated last month.

Niacinamide is one of the raw materials your skin uses to make more mortar. Supply more, and it builds more. When researchers applied it to real human skin under controlled conditions, mortar levels rose and water loss dropped, with the effect showing up in about four weeks.

STRATUM CORNEUMEPIDERMISDERMIS Petrolatum, squalane, dimethicone — sit here, slow water loss Niacinamide, vitamin C, azelaic acid — pigment and lipids Ceramides with cholesterol and fatty acids — rebuild the mortar Tretinoin — collagen lives down here, and so does the irritation Microneedling at 1.5 mm and above reaches this layer
Depth is most of the story. An ingredient that cannot reach the layer where the problem lives will not fix it, however good the marketing.

This is the strongest thing niacinamide does. It is also, reliably, printed in the smallest font on the box.

What that means in practice

  • If your skin stings, flakes, or has recently turned on you, this is your ingredient.
  • If you're chasing glow, it's a supporting actor, not the lead.
  • It works while you use it and stops when you stop. It's upkeep, not a cure.

The claim that's real but oversold

Pigment gets made in one type of cell and handed to its neighbours, a bit like passing a parcel down a row. Niacinamide doesn't stop the parcel being made. It makes the handover clumsier. Less pigment arrives at the surface, so spots fade.

That's a genuine effect, and it beat the identical cream minus the niacinamide when researchers treated one half of people's faces for eight weeks.

Here's the part we got wrong until this week. The one head-to-head trial we cite put 4% niacinamide on one side of people's faces and 4% hydroquinone, the prescription standard, on the other, for eight weeks. The instruments found no significant difference between the two sides. By eye, hydroquinone edged it: 55% of patients rated good-to-excellent, against 44%. Niacinamide caused fewer side effects, 18% against 29%. That's a far closer race than we implied. It's also twenty-seven people over eight weeks, which makes it a promising result rather than a settled one. And everyone in the trial wore sunscreen throughout, which likely did more for their melasma than either cream did.

A result can be real, repeatable, and still far too small for anyone to notice in a mirror. Those are three separate questions, and adverts only ever answer the first one.

The two claims that are thinner than they look

The oil-control reputation traces back largely to one study using 2% niacinamide in a small group of people. It's a perfectly reasonable study. It's also a single one, at a lower strength than most serums use, and nobody has repeated it at anything like the scale the marketing implies.

Wrinkles are a similar story with a different flaw. The 12-week split-face study did find significant improvements at 5%: fine lines, wrinkles, blotchiness, yellowing, judged from facial photographs, with elasticity measured by machine. So the effect cleared the statistical bar. What the study never asked is whether anyone noticed. “Significantly different from the other half of your face” and “visible to you in the mirror” are two different findings, and only the first one was measured. Add authors who worked for a company selling the ingredient, and C is where it sits.

The 10% question

Almost all the trial data sits between 2% and 5%. Above that, evidence of extra benefit thins out while reports of stinging go up. The high-percentage products that caused a wave of complaints a few years back were generally 10% or more.

We could not find a single published trial showing 10% beats 5% at anything. Until one exists, 5% is the sensible ceiling, and paying extra for double the concentration is paying extra for a bigger number.

Commonly misread

Nicotinamide tablets, at 500 mg twice a day, reduced new skin cancers in people at high risk in a large trial. That's a strong result: for a tablet, in people who'd already had multiple skin cancers, at a dose no serum comes close to. It is not evidence that your niacinamide serum prevents skin cancer. Sunscreen does that job.

The short version

Barrier: yes, and it's cheap. Dark spots: a bit, slowly, be patient. Oil: maybe. Wrinkles: put the money towards a retinoid instead. Strength: 4–5% is plenty.

This is general education, not medical advice. Nothing here accounts for your history, your medication or your skin, and none of it replaces assessment by a qualified clinician. Where we describe what research found, that is a description of a study — not a promise about you.

Revision history

  • Corrected the niacinamide vs. hydroquinone melasma comparison. Earlier text implied a clearer niacinamide advantage, but the trial itself found no significant difference on colorimetry, with hydroquinone rated better on visual assessment by a slim margin (55% vs 44% good-to-excellent) and niacinamide causing fewer side effects (18% vs 29%). The article and glance table were rewritten to say what the trial actually measured, not what a summary of it implied.

References

  1. Tanno O, Ota Y, Kitamura N, et al. Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier. British Journal of Dermatology, 2000.BCell-culture work plus topical application in humans·Kanebo (industry) laboratory, and the barrier effect in people was measured as water loss, not appearancePubMed 10971324DOI 10.1111/j.1365-2133.2000.03705.x
  2. Hakozaki T, Minwalla L, Zhuang J, et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. British Journal of Dermatology, 2002.BSplit-face, vehicle-controlled, 8 weeks·Procter & Gamble authors, industry-fundedPubMed 12100180DOI 10.1046/j.1365-2133.2002.04834.x
  3. Navarrete-Solís J, Castanedo-Cázares JP, Torres-Álvarez B, et al. A double-blind, randomized clinical trial of niacinamide 4% versus hydroquinone 4% in the treatment of melasma. Dermatology Research and Practice, 2011.BSplit-face RCT, n=27, 8 weeks·University-funded, no declared industry interest. Everyone wore sunscreen throughout, so neither cream was tested on its own. n=27 is small for a head-to-head.PubMed 21822427DOI 10.1155/2011/379173
  4. Draelos ZD, Matsubara A, Smiles K. The effect of 2% niacinamide on facial sebum production. Journal of Cosmetic and Laser Therapy, 2006.CTwo small vehicle-controlled studies, Japanese and US groups·Procter & Gamble authors, not widely repeated sincePubMed 16766489DOI 10.1080/14764170600717704
  5. Bissett DL, Oblong JE, Berge CA. Niacinamide: a B vitamin that improves aging facial skin appearance. Dermatologic Surgery, 2005.CSplit-face, vehicle-controlled, n=50, 5% niacinamide, 12 weeks·Procter & Gamble authors. Appearance endpoints were graded from facial photographs, and elasticity was measured by cutometry. Statistical significance was measured, visibility to the user was not.PubMed 16029679DOI 10.1111/j.1524-4725.2005.31732
  6. Chen AC, Martin AJ, Choy B, et al. A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention. New England Journal of Medicine, 2015.APhase 3 RCT, n=386, 12 months·Oral tablets at 500 mg twice daily, not a topical serumPubMed 26488693DOI 10.1056/NEJMoa1506197

Your turn

Did this hold up? Tell us honestly — especially if it didn’t.

Anonymous. Stored in your browser.

The Sunday study

One paper a week, explained properly

We pick a single new study, tell you what it measured, how many people it measured it in, and whether it should change anything you're doing — plus the two articles we published that week. No panic, and no hype.

We don't recommend products yet. When we do, they'll be things you can actually buy in India, any affiliate link will be labelled as one, and a commission will never buy a recommendation.

One email each Sunday. Unsubscribe in one click.